Purdue Pharma L.P.

Purdue Pharma and develops consumer health products to meet the evolving needs of healthcare professionals, patients, consumers and caregivers. In March 2025, Purdue filed a new Chapter 11 Plan of Reorganization and related disclosure statement with the United States Bankruptcy Court for the Southern District of New York. This plan of reorganization will deliver billions in value to communities across the country to fund programs specifically for abatement of the opioid crisis.The company is driven by its purpose: compassion for patients and excellence for science inspire pursuit of new medicines.